Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-19

FDA Approved: SINEMET — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for SINEMET (carbidopa/levodopa) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SINEMET (carbidopa and levodopa)

Snippet

SUPPL AP for SINEMET (CARBIDOPA AND LEVODOPA)